MRI breakthrough predicts kidney risks before surgery with unprecedented accuracy

Scientists at the Icahn School of Medicine at Mount Sinai have made a breakthrough in kidney surgery planning. Using advanced MRI techniques, they can now predict which patients face a higher risk of kidney function decline after nephrectomy. The findings could change how surgeons prepare for operations and monitor recovery. The research, led by Dr. Mira Liu, a postdoctoral fellow, focused on multiparametric MRI to assess kidney health before surgery. Her team discovered that kidneys showing poor baseline function or high stress levels on MRI scans were far more likely to worsen over time. These imaging markers proved more accurate than traditional methods in forecasting long-term kidney problems, including chronic kidney disease (CKD).

The study also revealed that MRI biomarkers offer insights beyond kidney resilience. They appear to reflect tumour immunobiology, providing a clearer picture of cancer aggressiveness. This dual capability means MRI could soon play a key role in both surgical planning and cancer treatment strategies.

Dr. Liu’s work earned her the W.S. Moore Award at the 2026 ISMRM & ISMRT Annual Meeting, recognising its potential impact. The Icahn School of Medicine continues to push for wider adoption of these techniques, encouraging collaboration across medical disciplines. Further validation studies are now underway to test the approach in different patient groups and healthcare settings. The adoption of multiparametric MRI could soon become routine in nephrectomy care. By pinpointing high-risk patients early, it allows for more precise surgical and postoperative management. This shift aligns with broader efforts to integrate precision medicine into kidney treatment.